Janssen Pharmaceutica NV
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Turnhoutseweg 30, Beerse, B-2340, Belgium (BEL)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002807336 · DUNS 370005019
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2025-09-05
- VAIDrug Quality Assurance2025-05-12
- VAIDrug Quality Assurance2021-07-02
- VAIDrug Quality Assurance2018-06-12
- VAIDrug Quality Assurance2016-03-01
- VAIDrug Quality Assurance2014-05-14
- NAIDrug Quality Assurance2012-09-27
- VAIDrug Quality Assurance2009-12-18
Drugs this plant is listed as making
12 distinct drugs across 38 products name this site in their FDA label.
- canagliflozin and metformin hydrochlorideJanssen Pharmaceuticals, Inc.
- DaratumumabJanssen Biotech, Inc.
- darunavirJanssen Products LP
- etravirinePatriot Pharmaceuticals
- gemcitabine intravesicalJanssen Biotech, Inc
- guselkumabJanssen Biotech, Inc.
- Haloperidol DecanoatePatriot Pharmaceuticals LLC
- paliperidone palmitateJanssen Pharmaceuticals, Inc.
- risperidoneJanssen Pharmaceuticals, Inc.
- teclistamab-cqyvJanssen Biotech, Inc.
- TrabectedinJanssen Products, LP
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.